Literature DB >> 29904965

Abnormalities in cortical interneuron subtypes in ephrin-B mutant mice.

Asghar Talebian1, Rachel Britton1, Mark Henkemeyer1.   

Abstract

To explore roles for ephrin-B/EphB signaling in cortical interneurons, we previously generated ephrin-B (Efnb1/b2/b3) conditional triple mutant (TMlz ) mice using a Dlx1/2.Cre inhibitory neuron driver and green fluorescent protein (GFP) reporters for the two main inhibitory interneuron groups distinguished by expression of either glutamic acid decarboxylase 1 (GAD1; GAD67-GFP) or 2 (GAD2; GAD65-GFP). This work showed a general involvement of ephrin-B in migration and population of interneurons into the embryonic neocortex. We now determined whether specific interneurons are selectively affected in the adult brains of TMlz .Cre mice by immunostaining with antibodies that identify the different subtypes. The results indicate that GAD67-GFP-expressing interneurons that also express parvalbumin (PV), calretinin (CR) and, to a lesser extent, somatostatin (SST) and Reelin (Rln) were significantly reduced in the cortex and hippocampal CA1 region in TMlz .Cre mutant mice. Neuropeptide Y (NPY) interneurons that also express GAD67-GFP were reduced in the hippocampal CA1 region, but much less so in the cortex, although these cells exhibited abnormal cortical layering. In GAD65-GFP-expressing interneurons, CR subtypes were reduced in both cortex and hippocampal CA1 region, whereas Rln interneurons were reduced exclusively in hippocampus, and the numbers of NPY and vasoactive intestinal polypeptide (VIP) subtypes appeared normal. PV and CR subtype interneurons in TMlz .Cre mice also exhibited reductions in their perisomatic area, suggesting abnormalities in dendritic/axonal complexity. Altogether, our data indicate that ephrin-B expression within forebrain interneurons is required in specific subtypes for their normal population, cortical layering and elaboration of cell processes.
© 2018 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  CA1; Eph-Ephrin bidirectional signaling; cortex; hippocampus; interneuron subtypes

Mesh:

Substances:

Year:  2018        PMID: 29904965      PMCID: PMC6105433          DOI: 10.1111/ejn.14022

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  36 in total

1.  Preferential origin and layer destination of GAD65-GFP cortical interneurons.

Authors:  Guillermina López-Bendito; Katherine Sturgess; Ferenc Erdélyi; Gábor Szabó; Zoltán Molnár; Ole Paulsen
Journal:  Cereb Cortex       Date:  2004-04-27       Impact factor: 5.357

Review 2.  Interneurons of the neocortical inhibitory system.

Authors:  Henry Markram; Maria Toledo-Rodriguez; Yun Wang; Anirudh Gupta; Gilad Silberberg; Caizhi Wu
Journal:  Nat Rev Neurosci       Date:  2004-10       Impact factor: 34.870

Review 3.  Neurons on the move: migration and lamination of cortical interneurons.

Authors:  Clare Faux; Sonja Rakic; William Andrews; Joanne M Britto
Journal:  Neurosignals       Date:  2012-05-04

4.  Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.

Authors:  Laure Verret; Edward O Mann; Giao B Hang; Albert M I Barth; Inma Cobos; Kaitlyn Ho; Nino Devidze; Eliezer Masliah; Anatol C Kreitzer; Istvan Mody; Lennart Mucke; Jorge J Palop
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

Review 5.  Interneuron dysfunction in psychiatric disorders.

Authors:  Oscar Marín
Journal:  Nat Rev Neurosci       Date:  2012-01-18       Impact factor: 34.870

6.  Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons.

Authors:  Lei Wen; Yi-Sheng Lu; Xin-Hong Zhu; Xiao-Ming Li; Ran-Sook Woo; Yong-Jun Chen; Dong-Min Yin; Cary Lai; Alvin V Terry; Almira Vazdarjanova; Wen-Cheng Xiong; Lin Mei
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-29       Impact factor: 11.205

7.  A robust and high-throughput Cre reporting and characterization system for the whole mouse brain.

Authors:  Linda Madisen; Theresa A Zwingman; Susan M Sunkin; Seung Wook Oh; Hatim A Zariwala; Hong Gu; Lydia L Ng; Richard D Palmiter; Michael J Hawrylycz; Allan R Jones; Ed S Lein; Hongkui Zeng
Journal:  Nat Neurosci       Date:  2009-12-20       Impact factor: 24.884

Review 8.  The involvement of Reelin in neurodevelopmental disorders.

Authors:  Timothy D Folsom; S Hossein Fatemi
Journal:  Neuropharmacology       Date:  2012-09-07       Impact factor: 5.250

9.  A dual shaping mechanism for postsynaptic ephrin-B3 as a receptor that sculpts dendrites and synapses.

Authors:  Nan-Jie Xu; Suya Sun; Jay R Gibson; Mark Henkemeyer
Journal:  Nat Neurosci       Date:  2011-10-02       Impact factor: 24.884

10.  A dual role of EphB1/ephrin-B3 reverse signaling on migrating striatal and cortical neurons originating in the preoptic area: should I stay or go away?

Authors:  Judith Rudolph; Katrin Gerstmann; Geraldine Zimmer; André Steinecke; Annika Döding; Jürgen Bolz
Journal:  Front Cell Neurosci       Date:  2014-07-18       Impact factor: 5.505

View more
  3 in total

1.  Astrocytic Ephrin-B1 Controls Excitatory-Inhibitory Balance in Developing Hippocampus.

Authors:  Amanda Q Nguyen; Samantha Sutley; Jordan Koeppen; Karen Mina; Simone Woodruff; Sandy Hanna; Alekya Vengala; Peter W Hickmott; Andre Obenaus; Iryna M Ethell
Journal:  J Neurosci       Date:  2020-08-12       Impact factor: 6.167

2.  Reelin Can Modulate Migration of Olfactory Ensheathing Cells and Gonadotropin Releasing Hormone Neurons via the Canonical Pathway.

Authors:  Leigh Dairaghi; Ellen Flannery; Paolo Giacobini; Aybike Saglam; Hassan Saadi; Stephanie Constantin; Filippo Casoni; Brian W Howell; Susan Wray
Journal:  Front Cell Neurosci       Date:  2018-08-03       Impact factor: 5.505

3.  RNA-seq co-expression network analysis reveals anxiolytic behavior of mice with Efnb2 knockout in parvalbumin+ neurons.

Authors:  Ying Sun; Le Ma; Jianhua Chen; Weidi Wang; Shiyu Peng; Ying Cheng; Yu Zhang; Jinghong Chen; Peijun Ju
Journal:  Mol Brain       Date:  2021-07-19       Impact factor: 4.041

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.